8,000+ Others
For Restitution!
Fill Out The Form Below To Get Your Case Reviewed
SIGNIFICANT Compensation May Be Available
ACT NOW - TIME IS RUNNING OUT TO TAKE ACTION!
Widely Used Heartburn Medication Recalled Due to Cancer Risks
Zantac Recalled by FDA Due to Elevated Levels of Potential Carcinogen Nitrosodimethylamine (NDMA)
Zantac neglected to inform the general population regarding the presence of this compound within their product, prioritizing financial gain over the well-being of consumers.
While the FDA sets a permissible daily intake of 96 nanograms of NDMA, analytical assessments divulged that each tablet harbored an excess of 3,000,000 nanograms. This staggering quantity is an overabundance of 3,000 times the FDA's established intake threshold.
TortClaims Procedure
Sign-Up
In case you think you’re eligible for legal help and assistance we suggest signing up in the form above.
Consult
A legal representative will reach out to you to discuss your situation and needs. Drawing on their expertise and your experience, they will determine if you potentially qualify for potential compensation.
Paperwork
If you are deemed eligible for compensation, the team will forward a contract to include your details.
Verdict & Compensation
Winning a trial gets plaintiffs compensatory damages to cover losses. Serious cases might also receive punitive damages. Settlements mean agreed compensation for plaintiffs.
How may we be of assistance to you?
Zantac (ranitidine)
Zantac (ranitidine) is employed for addressing heartburn, acid indigestion, GERD, and gastric ulcers. It pertains to a category of medications known as H2 blockers. A recall was initiated by the FDA following the discovery that Zantac formulated with ranitidine contained the carcinogenic compound NDMA.
The precise catalysts behind these genetic alterations remain uncertain to doctors and researchers. Nevertheless, certain recognized risk factors exist. Nexium, Prilosec, Pepcid.